Vanguard Capital Management
MGNX icon

Vanguard Capital Management’s MacroGenics MGNX Stock Holding History

Vanguard Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Buy
2,656,010
+2,157
+0.1% +$8.16K ﹤0.01% 2701
2026
Q1 		$7.67M Buy
+2,653,853
New +$5.66M ﹤0.01% 2870

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management's MGNX Position: Q2 2026 in Review

Vanguard Capital Management increased its MacroGenics (MGNX) stake by 0.08% in Q2 2026, buying an estimated $8.16K and bringing the position to 2,656,010 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Vanguard Capital Management first reported a position in MGNX in Q1 2026 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Vanguard Capital Management held 2,656,010 shares of MacroGenics worth $12.3M as of Q2 2026.
  • Vanguard Capital Management bought 2,157 MacroGenics shares in Q2 2026, an estimated $8.16K.
  • MacroGenics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2701 holding.
  • Vanguard Capital Management first reported a position in MacroGenics in Q1 2026 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.